In vivo selective expansion of gene-modified hematopoietic cells in a nonhuman primate model.
A major problem limiting hematopoietic stem cell (HSC) gene therapy is the low efficiency of gene transfer into human HSCs using retroviral vectors. Strategies, which would allow in vivo expansion of gene-modified hematopoietic cells, could circumvent the problem. To this end, we developed a selective amplifier gene (SAG) consisting of a chimeric gene composed of the granulocyte colony-stimulating factor (G-CSF) receptor gene and the estrogen receptor gene hormone-binding domain. We have previously demonstrated that primary bone marrow progenitor cells transduced with the SAG could be expanded in response to estrogen in vitro. In the present study, we evaluated the efficacy of the SAG in the setting of a clinically applicable cynomolgus monkey transplantation protocol. Cynomolgus bone marrow CD34(+) cells were transduced with retroviral vectors encoding the SAG and reinfused into each myeloablated monkey. Three of the six monkeys that received SAG transduced HSCs showed an increase in the levels of circulating progeny containing the provirus in vivo following administration of estrogen or tamoxifen without any serious adverse effects. In one monkey examined in detail, transduced hematopoietic progenitor cells were increased by several-fold (from 5% to 30%). Retroviral integration site analysis revealed that this observed increase was polyclonal and no outgrowth of a dominant single clonal population was observed. These results demonstrate that the inclusion of our SAG in the retroviral construct allows selective in vivo expansion of genetically modified cells by a non-toxic hormone treatment.
Division of Genetic Therapeutics, Center for Molecular Medicine, Jichi Medical School, Tochigi, Japan.
Y
Y
Hanazono
T
T
Nagashima
M
M
Takatoku
H
H
Shibata
N
N
Ageyama
T
T
Asano
Y
Y
Ueda
C E
CE
Dunbar
A
A
Kume
K
K
Terao
M
M
Hasegawa
K
K
Ozawa
D000818:Animals; D018952:Antigens, CD34 / Q000032:analysis; D002455:Cell Division; D005260:Female; D005784:Gene Amplification; D018014:Gene Transfer Techniques; D005819:Genetic Markers; D015316:Genetic Therapy / Q000379:methods*; D005822:Genetic Vectors; D018380:Hematopoietic Stem Cell Transplantation; D006412:Hematopoietic Stem Cells / Q000166:cytology*; D008252:Macaca fascicularis; D008297:Male; D011960:Receptors, Estrogen / Q000235:genetics; D016188:Receptors, Granulocyte Colony-Stimulating Factor / Q000235:genetics; D012190:Retroviridae / Q000235:genetics
D018952:Antigens, CD34; D005819:Genetic Markers; D011960:Receptors, Estrogen; D016188:Receptors, Granulocyte Colony-Stimulating Factor